4.4 Article

Isolation and Characterization of a Novel Phage SaGU1 that Infects Staphylococcus aureus Clinical Isolates from Patients with Atopic Dermatitis

期刊

CURRENT MICROBIOLOGY
卷 78, 期 4, 页码 1267-1276

出版社

SPRINGER
DOI: 10.1007/s00284-021-02395-y

关键词

-

资金

  1. Japan Society for the Promotion of Science (JSPS), KAKENHI [15K21770]
  2. Gunma University Medical Innovation Project
  3. Grants-in-Aid for Scientific Research [15K21770] Funding Source: KAKEN

向作者/读者索取更多资源

A novel bacteriophage SaGU1 was characterized in this study from sewage samples in Japan, showing potential as a phage therapy agent against S. aureus infections. SaGU1 demonstrated heat stability, lytic activity, and a broad host range targeting clinical isolates of S. aureus on the skin of AD patients. It is considered a promising candidate for developing phage therapy to treat AD caused by pathogenic S. aureus.
The bacterium Staphylococcus aureus, which colonizes healthy human skin, may cause diseases, such as atopic dermatitis (AD). Treatment for such AD cases involves antibiotic use; however, alternate treatments are preferred owing to the development of antimicrobial resistance. This study aimed to characterize the novel bacteriophage SaGU1 as a potential agent for phage therapy to treat S. aureus infections. SaGU1 that infects S. aureus strains previously isolated from the skin of patients with AD was screened from sewage samples in Gifu, Japan. Its genome was sequenced and analyzed using bioinformatics tools, and the morphology, lytic activity, stability, and host range of the phage were determined. The SaGU1 genome was 140,909 bp with an average GC content of 30.2%. The viral chromosome contained 225 putative protein-coding genes and four tRNA genes, carrying neither toxic nor antibiotic resistance genes. Electron microscopy analysis revealed that SaGU1 belongs to the Myoviridae family. Stability tests showed that SaGU1 was heat-stable under physiological and acidic conditions. Host range testing revealed that SaGU1 can infect a broad range of S. aureus clinical isolates present on the skin of AD patients, whereas it did not kill strains of Staphylococcus epidermidis, which are symbiotic resident bacteria on human skin. Hence, our data suggest that SaGU1 is a potential candidate for developing a phage therapy to treat AD caused by pathogenic S. aureus.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据